Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Journal of Computer-Aided Molecular Design
|
October 12, 2013
ALOHA: a novel probability fusion approach for scoring multi-parameter drug-likeness during the lead optimization stage of drug discovery
Derek A Debe, Ravindra B Mamidipaka, Robert J Gregg, et al.
Journal of Chemical Information and Modeling
|
April 18, 2008
Application of belief theory to similarity data fusion for use in analog searching and lead hopping
Steven W Muchmore, Derek A Debe, James T Metz, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 27, 2003
Novel and selective imidazole-containing biphenyl inhibitors of protein farnesyltransferase
Michael L Curtin, Alan S Florjancic, Jerome Cohen, et al.
Journal of Medicinal Chemistry
|
December 17, 2008
Synthesis and evaluation of benzothiazole-based analogues as novel, potent, and selective fatty acid amide hydrolase inhibitors
Xueqing Wang, Katerina Sarris, Karen Kage, et al.
Journal of Medicinal Chemistry
|
September 17, 2004
NMR-driven discovery of benzoylanthranilic acid inhibitors of far upstream element binding protein binding to the human oncogene c-myc promoter
Jeffrey R Huth, Liping Yu, Irene Collins, et al.
Journal of Medicinal Chemistry
|
February 18, 2010
Molecular shape and medicinal chemistry: a perspective
Anthony Nicholls, Georgia B McGaughey, Robert P Sheridan, et al.
Journal of Medicinal Chemistry
|
December 13, 2006
Crystal structures of human adenosine kinase inhibitor complexes reveal two distinct binding modes
Steven W Muchmore, Richard A Smith, Andrew O Stewart, et al.
Bioorganic & Medicinal Chemistry
|
January 2, 2007
4-amino-5-aryl-6-arylethynylpyrimidines: structure-activity relationships of non-nucleoside adenosine kinase inhibitors
Mark A Matulenko, Ernest S Paight, Robin R Frey, et al.
Anti-Cancer Drugs
|
October 14, 2005
A highly potent and selective farnesyltransferase inhibitor ABT-100 in preclinical studies
Wen-Zhen Gu, Ingrid Joseph, Yi-Chun Wang, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Journal of Computer-Aided Molecular Design
|
October 12, 2013
ALOHA: a novel probability fusion approach for scoring multi-parameter drug-likeness during the lead optimization stage of drug discovery
Derek A Debe, Ravindra B Mamidipaka, Robert J Gregg, et al.
Journal of Chemical Information and Modeling
|
April 18, 2008
Application of belief theory to similarity data fusion for use in analog searching and lead hopping
Steven W Muchmore, Derek A Debe, James T Metz, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 27, 2003
Novel and selective imidazole-containing biphenyl inhibitors of protein farnesyltransferase
Michael L Curtin, Alan S Florjancic, Jerome Cohen, et al.
Journal of Medicinal Chemistry
|
December 17, 2008
Synthesis and evaluation of benzothiazole-based analogues as novel, potent, and selective fatty acid amide hydrolase inhibitors
Xueqing Wang, Katerina Sarris, Karen Kage, et al.
Journal of Medicinal Chemistry
|
September 17, 2004
NMR-driven discovery of benzoylanthranilic acid inhibitors of far upstream element binding protein binding to the human oncogene c-myc promoter
Jeffrey R Huth, Liping Yu, Irene Collins, et al.
Journal of Medicinal Chemistry
|
February 18, 2010
Molecular shape and medicinal chemistry: a perspective
Anthony Nicholls, Georgia B McGaughey, Robert P Sheridan, et al.
Journal of Medicinal Chemistry
|
December 13, 2006
Crystal structures of human adenosine kinase inhibitor complexes reveal two distinct binding modes
Steven W Muchmore, Richard A Smith, Andrew O Stewart, et al.
Bioorganic & Medicinal Chemistry
|
January 2, 2007
4-amino-5-aryl-6-arylethynylpyrimidines: structure-activity relationships of non-nucleoside adenosine kinase inhibitors
Mark A Matulenko, Ernest S Paight, Robin R Frey, et al.
Anti-Cancer Drugs
|
October 14, 2005
A highly potent and selective farnesyltransferase inhibitor ABT-100 in preclinical studies
Wen-Zhen Gu, Ingrid Joseph, Yi-Chun Wang, et al.
Page
of 2